Pediatric myasthenia gravis with a combination of AChR and RyR is associated with an earlier onset and lower CSR rate: A cohort study in southwest China

CONCLUSIONS: We summarized one of the largest cohorts of pediatric MG patients and compared the clinical phenotype of patients with antibody-negative, AChR-positive, and AChR with or without titin and RyR antibodies. The results showed that patients with AChR and RyR antibodies had a younger onset age, a higher immunosuppressant use rate and a lower CSR rate.PMID:37639776 | DOI:10.1016/j.ejpn.2023.08.002

Source: European Journal of Paediatric Neurology - August 28, 2023 Category: Neurology Authors: Jie Liu Jiannan Ma Siqi Hong Li Jiang Tianyi Li Source Type: research